IL151280A0 - Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response - Google Patents

Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Info

Publication number
IL151280A0
IL151280A0 IL15128001A IL15128001A IL151280A0 IL 151280 A0 IL151280 A0 IL 151280A0 IL 15128001 A IL15128001 A IL 15128001A IL 15128001 A IL15128001 A IL 15128001A IL 151280 A0 IL151280 A0 IL 151280A0
Authority
IL
Israel
Prior art keywords
enhancement
immune response
carbohydrate formulation
prebiotic
adjuvant
Prior art date
Application number
IL15128001A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of IL151280A0 publication Critical patent/IL151280A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
IL15128001A 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response IL151280A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
IL151280A0 true IL151280A0 (en) 2003-04-10

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15128001A IL151280A0 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Country Status (22)

Country Link
US (2) US20030040492A1 (de)
EP (1) EP1261355B1 (de)
JP (1) JP4838477B2 (de)
KR (1) KR20020081375A (de)
CN (1) CN1243551C (de)
AR (1) AR027968A1 (de)
AT (1) ATE283697T1 (de)
AU (2) AU2001231746C1 (de)
BR (1) BR0108828A (de)
CA (1) CA2400969C (de)
DE (1) DE60107544T2 (de)
ES (1) ES2232591T3 (de)
HK (1) HK1051650A1 (de)
HU (1) HUP0204546A3 (de)
IL (1) IL151280A0 (de)
MX (1) MXPA02008447A (de)
NO (1) NO20024011D0 (de)
PL (1) PL365136A1 (de)
PT (1) PT1261355E (de)
UA (1) UA73763C2 (de)
WO (1) WO2001064225A1 (de)
ZA (1) ZA200207849B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008046625A2 (en) * 2006-10-18 2008-04-24 Dsm Ip Assets B.V. Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (de) * 2007-08-24 2010-05-26 Barry Callebaut AG Verfahren und hiermit hergestelltes konfektprodukt
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110097437A1 (en) 2008-06-13 2011-04-28 N.V. Nutricia Nutrition for prevention of infections
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
BRPI1008280A2 (pt) 2009-02-24 2015-08-25 Ritter Pharmaceuticals Inc Formulações prebióticas e métodos mde uso
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
EP2662084A1 (de) 2009-07-15 2013-11-13 N.V. Nutricia Mischung enthaltend nicht verdauliche Oligosaccharide zur Stimulierung des Immunsystems
RU2530641C2 (ru) 2009-07-15 2014-10-10 Н.В. Нютрисиа Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой
ES2545597T3 (es) 2009-11-12 2015-09-14 Nestec S.A. Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud
EP2563372A4 (de) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Präbiotische formulierungen und verwendungsverfahren dafür
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
ES2760351T3 (es) * 2015-08-04 2020-05-13 Suedzucker Ag Utilización profiláctica de inulina contra la sinusitis
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
KR20200053531A (ko) 2017-09-08 2020-05-18 에벨로 바이오사이언시즈, 인크. 박테리아 세포외 소포
JP2020533291A (ja) * 2017-09-08 2020-11-19 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954622A (en) * 1985-10-31 1990-09-04 The Australian National University Pharmaceutical composition and method containing gamma inulin or derivative thereof
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
EP0692252B1 (de) * 1994-06-14 2001-04-04 "Raffinerie Tirlemontoise", société anonyme: Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
EP0856259B1 (de) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
AU2001231746B2 (en) 2004-12-23
UA73763C2 (en) 2005-09-15
NO20024011L (no) 2002-08-22
HK1051650A1 (en) 2003-08-15
CN1243551C (zh) 2006-03-01
AU2001231746C1 (en) 2005-10-06
WO2001064225A1 (en) 2001-09-07
JP4838477B2 (ja) 2011-12-14
JP2003533438A (ja) 2003-11-11
AU3174601A (en) 2001-09-12
US20030040492A1 (en) 2003-02-27
HUP0204546A2 (en) 2003-05-28
CN1422158A (zh) 2003-06-04
US7101553B2 (en) 2006-09-05
BR0108828A (pt) 2002-12-10
DE60107544D1 (de) 2005-01-05
PT1261355E (pt) 2005-02-28
CA2400969C (en) 2011-04-19
ATE283697T1 (de) 2004-12-15
AR027968A1 (es) 2003-04-16
DE60107544T2 (de) 2005-12-15
HUP0204546A3 (en) 2003-10-28
MXPA02008447A (es) 2002-12-13
PL365136A1 (en) 2004-12-27
NO20024011D0 (no) 2002-08-22
CA2400969A1 (en) 2001-09-07
EP1261355B1 (de) 2004-12-01
ZA200207849B (en) 2003-12-30
US20040191234A1 (en) 2004-09-30
ES2232591T3 (es) 2005-06-01
KR20020081375A (ko) 2002-10-26
EP1261355A1 (de) 2002-12-04

Similar Documents

Publication Publication Date Title
AU3174601A (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
IL218666A0 (en) Enhancement of antibody-medicated immune responses
EP1467615A4 (de) Verfahren für die rekombinante veränderung von kohlenhydratstrukturen des säugetiertyps
HUP0200815A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
GB2361186B (en) Formulation for the prevention of cardiovascular disease
EP1461074A4 (de) Mittel zur verstärkung der immunantwort
HUP0203972A3 (en) Composition of antigen and glycolipid adjuvant sublingual administration
EP1352980A4 (de) Siliciumreicher nichtrostender stahl
GB2364642B (en) Compositions for enhancing the immune response
HUP0201220A2 (en) Adjuvant combination formulations
GB2376797B (en) Stable oxide-free silicon surface preparation
PT1446107E (pt) Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
HK1047406A1 (zh) Hiv免疫佐劑治療
GB0114151D0 (en) Mounting structure of semiconductor packeage
EP1313839A4 (de) Immunsystem steigernde zusammensetzungen
IL155690A0 (en) Adjuvant combination formulations
SI1187629T1 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
AU6604701A (en) Method to induce the TH1 immune response
DK1261355T3 (da) Carbohydratformulering (præbiotisk adjuvans) til forstærkning af immunresponset
EP1264600A4 (de) ZUSAMMENSETZUNGEN ZUR VERSTäRKUNG DER IMMUNITäT UND IHRE VERWENDUNG
HRP20030777A2 (en) Preparation and isolation of indolocarbazole glycosides
AU2002364161A8 (en) Enhancement of the immune response using cd36-binding domain
AU2001266669A1 (en) Adjuvant preparation for the induction of specific immunity
AU2002358680A1 (en) Device for improving the rinse effect of dishwashers
AU2002326582A1 (en) Immune tolerance to predetermined antigens